Terms: = Brain cancer AND DDX6, P54, 1656, ENSG00000110367, HLR2, P26196, RCK, FLJ36338 AND Treatment
4 results:
1. MSK1-Mediated β-Catenin Phosphorylation Confers Resistance to PI3K/mTOR Inhibitors in Glioblastoma.
Wu S; Wang S; Zheng S; Verhaak R; Koul D; Yung WK
Mol Cancer Ther; 2016 Jul; 15(7):1656-68. PubMed ID: 27196759
[TBL] [Abstract] [Full Text] [Related]
2. Involvement of ddx6 gene in radio- and chemoresistance in glioblastoma.
Cho YJ; Kang W; Kim SH; Sa JK; Kim N; Paddison PJ; Kim M; Joo KM; Hwang YI; Nam DH
Int J Oncol; 2016 Mar; 48(3):1053-62. PubMed ID: 26783102
[TBL] [Abstract] [Full Text] [Related]
3. Protein kinase D2 regulates migration and invasion of U87MG glioblastoma cells in vitro.
Bernhart E; Damm S; Wintersperger A; DeVaney T; Zimmer A; Raynham T; Ireson C; Sattler W
Exp Cell Res; 2013 Aug; 319(13):2037-2048. PubMed ID: 23562655
[TBL] [Abstract] [Full Text] [Related]
4. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract] [Full Text] [Related]
